About Us

---

At New Hope Molecular, we couple breakthrough scientific advances with personalized medicine to revolutionize the treatment of refractory psychiatric illness.

Our mission is to identify underlying metabolic and genetic conditions contributing to treatment refractory psychiatric illness, to advance characterization of mental health disorders, and to guide the most cutting edge testing and treatment options for patients with treatment refractory mental illness.

Clients receive a full psychiatric evaluation and record review, comprehensive clinical metabolomic and genomic testing, and an individualized, data-driven analysis of the results. A comprehensive report is generated for your doctor to guide your care.  

Lisa Pan, M.D., F.A.P.A.  

Founder

Over the past 20 years, Dr. Pan has investigated the neurobiology of suicide attempt and treatment refractory depression in adolescents and young adults, utilizing cutting-edge, clinically-validated methods in functional neuroimaging and metabolomics to characterize suicidal behavior. Dr. Pan is board certified in Psychiatry and Neurology, with subspecialty certification in Child and Adolescent Psychiatry and has over a decade of work with teens and adults at risk for suicide. Among her many honors and awards, she received a Department of Defense  National Security Council Education Program Scholarship, was named an  AACAP Presidential Scholar, received an American Foundation for Suicide Prevention Young Investigator Grant, an NIH K23 Mentored Patient-Oriented Career Development Award, and a NARSAD Young Investigator Award from the Brain and Behavior Research Foundation. She maintains an active clinical practice in Mt. Lebanon, PA.  

David Finegold, M.D. 

Metabolic Lab Director

Dr. Finegold is an endocrinologist and biochemical geneticist. He is a faculty member in the Department of Human Genetics at University of Pittsburgh, where his research focuses on lymphatic vascular biology and genetic variation underlying primary and secondary lymphedema. Dr. Finegold is certified by the American Board of Pediatrics, the American Board of Pediatric Endocrinology, and the American Board of Medical Genetics (Biochemical Genetics). He is the co-principal investigator for the Pittsburgh Lymphedema Family Study, which aims to identify genes responsible for primary lymphedema as well as a co-investigator in Dr. Massimo Trucco's studies to rescue newly diagnosed patients with type I diabetes mellitus. He also advises two analytical chemistry groups developing novel biomolecular sensors and a chemical engineering sensing and modeling group. Prior to the founding of New Hope Molecular, he advised and served as a geneticist for Dr. Lisa Pan's suicide research group. 

Kelly Bayles, R.N.

Registered Nurse 

Nurse Bayles graduated from Waynesburg University with a bachelors degree in biology and a minor in exercise science. She then received a bachelors of science in nursing through the accelerated program at Waynesburg University. She has been a registered nurse for 17 years. She worked 10 years at Monongalia Hospital in Morgantown for 10 years on the cardiac intensive care unit floor. She has worked the last 7 years for an Infusion pharmacy as a nursing supervisor for Pennsylvania and West Virginia. She has three years of experience in psychiatric nursing at Axiom Family Counseling.

Bryan Overton, M.B.A.

Operations

Bryan Overton has over 25 years of business and project management experience in the healthcare field.  He has worked extensively implementing large complex technical projects, managing teams, and delivering healthcare solutions at many of the leading healthcare institutions in the Northeastern United States; including UPMC, New York Presbyterian, Mt. Sinai, Dartmouth-Hitchcock, Walter Reed Army Medical Center, and Fort Belvoir to name a few.  He graduated from University of Maryland Baltimore County with a Bachelors in Information Systems, and received an Masters of Business Administration from Loyola University Maryland in 2000.   

Patricia Dobosh, Ph.D. 

Psychologist

Dr. Dobosh is a licensed Clinical Psychologist who has been practicing for the last 20 years. She specializes in Behavioral Medicine and Cognitive-Behavioral Therapy. Dr. Dobosh is trained in Dialectical Behavior Therapy in addition to other empirically-validated treatments. Furthermore, she is an expert psychometrician with considerable experience in making differential diagnoses and identifying underlying and complicated clinical concerns. Dr. Dobosh is a graduate of Gallaudet University in Washington, District of Columbia and completed her clinical training at the Louis Stokes Department of Veterans Affairs Medical Center in Cleveland, Ohio. She continues to maintain a separate clinical practice in Pittsburgh, Pennsylvania.   

Angela Wagner, M.S.

Data Analyst

Gary Kaplan, Esq. 

Legal Counsel

Gary Kaplan is an attorney with more than 35 years experience working with companies and nonprofit organizations.  He has worked extensively with health care organizations, technology companies, emerging companies and University tech transfer offices. A graduate of Yale University and The University of Chicago Law School, Mr. Kaplan has also taught health law at Heinz College of Carnegie Mellon University and written two books and numerous articles.